|Double-detargeted oncolytic adenovirus shows replication arrest in liver cells and retains neuroendocrine cell killing ability|
J Leja, B Nilsson, D Yu, E Gustafson, G Åkerström, K Öberg, ...
PLoS One 5 (1), e8916, 2010
|Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors|
D Yu, C Jin, J Leja, N Majdalani, B Nilsson, F Eriksson, M Essand
Journal of virology 85 (24), 13114-13123, 2011
|The Tardigrada fauna of China with descriptions of three new species of Echiniscidae|
XC Li, LZ Wang, D Yu
ZOOLOGICAL STUDIES-TAIPEI- 46 (2), 135, 2007
|Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures|
D Yu, C Jin, M Ramachandran, J Xu, B Nilsson, O Korsgren, K Le Blanc, ...
PLoS One 8 (1), e54952, 2013
|Safe engineering of CAR T cells for adoptive cell therapy of cancer using long‐term episomal gene transfer|
C Jin, G Fotaki, M Ramachandran, B Nilsson, M Essand, D Yu
EMBO molecular medicine 8 (7), 702-711, 2016
|Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas|
L Zhang, S Kundu, T Feenstra, X Li, C Jin, L Laaniste, TEA El Hassan, ...
Sci. Signal. 8 (406), ra125-ra125, 2015
|Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells|
J Leja, D Yu, B Nilsson, L Gedda, A Zieba, T Hakkarainen, G Åkerström, ...
Gene therapy 18 (11), 1052, 2011
|Chondroitin Sulfate‐Coated DNA‐Nanoplexes Enhance Transfection Efficiency by Controlling Plasmid Release from Endosomes: A New Insight into Modulating Nonviral Gene Transfection|
H Yan, OP Oommen, D Yu, J Hilborn, H Qian, OP Varghese
Advanced Functional Materials 25 (25), 3907-3915, 2015
|An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors|
M Ramachandran, D Yu, A Wanders, M Essand, F Eriksson
Molecular Therapy 21 (11), 2008-2018, 2013
|Safe and effective treatment of experimental neuroblastoma and glioblastoma using systemically delivered triple microRNA-detargeted oncolytic Semliki Forest virus|
M Ramachandran, D Yu, M Dyczynski, S Baskaran, L Zhang, A Lulla, ...
Clinical Cancer Research 23 (6), 1519-1530, 2017
|Vector-encoded Helicobacter pylori neutrophil-activating protein promotes maturation of dendritic cells with Th1 polarization and improved migration|
M Ramachandran, C Jin, D Yu, F Eriksson, M Essand
The Journal of Immunology 193 (5), 2287-2296, 2014
|Quantized consensus on first-order integrator networks|
Y Wang, Q Wu, Y Wang, D Yu
Systems & Control Letters 61 (12), 1145-1150, 2012
|CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis|
R Lugano, K Vemuri, D Yu, M Bergqvist, A Smits, M Essand, S Johansson, ...
The Journal of clinical investigation 128 (8), 2018
|Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factors|
C Jin, D Yu, V Hillerdal, AC Wallgren, A Karlsson-Parra, M Essand
Molecular Therapy-Methods & Clinical Development 1, 14001, 2014
|Prospects to improve chimeric antigen receptor T-cell therapy for solid tumors|
C Jin, D Yu, M Essand
Immunotherapy 8 (12), 1355-1361, 2016
|Inhibition of heparanase in pediatric brain tumor cells attenuates their proliferation, invasive capacity, and in vivo tumor growth|
A Spyrou, S Kundu, L Haseeb, D Yu, T Olofsson, K Dredge, E Hammond, ...
Molecular cancer therapeutics 16 (8), 1705-1716, 2017
|Consensus algorithm for multiple quadrotor systems under fixed and switching topologies|
Y Wang, Q Wu, Y Wang, D Yu
Journal of Systems Engineering and Electronics 24 (5), 818-827, 2013
|Tat-PTD-modified oncolytic adenovirus driven by the SCG3 promoter and ASH1 enhancer for neuroblastoma therapy|
C Jin, D Yu, M Čančer, B Nilsson, J Leja, M Essand
Human gene therapy 24 (8), 766-775, 2013
|Preclinical evaluation of advince, an oncolytic adenovirus adapted for treatment of liver metastases from neuroendocrine cancer|
D Yu, J Leja-Jarblad, A Loskog, P Hellman, V Giandomenico, K Oberg, ...
Neuroendocrinology 105 (1), 54-66, 2017
|Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in …|
G Fotaki, C Jin, IK Kerzeli, M Ramachandran, MM Martikainen, ...
Oncoimmunology 7 (3), e1397250, 2018